Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Alcidion Group Limited ( (AU:ALC) ) has provided an announcement.
At its 2025 Annual General Meeting, Alcidion Group Limited announced that all resolutions were decided by poll, with the adoption of the Remuneration Report and the election of Andrew Way as a Director both carried. The approval of a 10% Placement Facility was withdrawn. These outcomes reflect Alcidion’s continued focus on strategic governance and operational decisions that align with its mission to enhance healthcare delivery.
The most recent analyst rating on (AU:ALC) stock is a Buy with a A$0.13 price target. To see the full list of analyst forecasts on Alcidion Group Limited stock, see the AU:ALC Stock Forecast page.
More about Alcidion Group Limited
Alcidion Group Limited is a company focused on transforming healthcare through smart and intuitive technology solutions aimed at improving patient care efficiency and quality globally. Their flagship product, Miya Precision, offers software products and technical services that enhance interoperability, communication, and clinical decision support, thereby improving patient outcomes.
Average Trading Volume: 907,037
Technical Sentiment Signal: Hold
Current Market Cap: A$124.9M
For a thorough assessment of ALC stock, go to TipRanks’ Stock Analysis page.